3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
9
Neoplasms
3
Brain Neoplasms
3
Medulloblastoma
2
Glioma
2
Sarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
tislelizumab
3
toripalimab
1
tazemetostat
1
sintilimab
1
pembrolizumab
1
osimertinib
1
enzalutamide
1
envafolimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Specimen Handling
1
Radiotherapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Injections
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Lomustine
×
90 days
×
Clear all
No trials found.